200,000+ products from a single source!

sales@angenechem.com

Home > Iodo > 128192-12-1

128192-12-1

128192-12-1 | 5-iodobenzovesamicol

CAS No: 128192-12-1 Catalog No: AG00AI99 MDL No:

Product Description

Catalog Number:
AG00AI99
Chemical Name:
5-iodobenzovesamicol
CAS Number:
128192-12-1
IUPAC Name:
(2R,3R)-5-iodo-3-(4-phenylpiperidin-1-yl)-1,2,3,4-tetrahydronaphthalen-2-ol
InChI:
InChI=1S/C21H24INO/c22-19-8-4-7-17-13-21(24)20(14-18(17)19)23-11-9-16(10-12-23)15-5-2-1-3-6-15/h1-8,16,20-21,24H,9-14H2/t20-,21-/m1/s1
InChI Key:
FHYAUNJNVMGZQN-NHCUHLMSSA-N

Properties

Complexity:
403  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
433.09g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
433.333g/mol
Monoisotopic Mass:
433.09g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
23.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
4.6  

Literature

Title Journal
Correlation of the vesicular acetylcholine transporter densities in the striata to the clinical abilities of women with Rett syndrome. Synapse (New York, N.Y.) 20120601
3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT). Bioorganic & medicinal chemistry 20101101
Comparison of noninvasive quantification methods of in vivo vesicular acetylcholine transporter using [123I]-IBVM SPECT imaging. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20080901
Ex vivo and in vivo evaluation of (2R,3R)-5-[(18)F]-fluoroethoxy- and fluoropropoxy-benzovesamicol, as PET radioligands for the vesicular acetylcholine transporter. Synapse (New York, N.Y.) 20071201
Decreased vesicular acetylcholine transporter and alpha(4)beta(2) nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning. Neuroscience letters 20070326
REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA. Neurology 20030708
Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA. Neurology 20030708
Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia. Annals of neurology 20030401
Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. The Journal of clinical endocrinology and metabolism 20010201

Related Products

© 2019 Angene International Limited. All rights Reserved.